Drug discovery firm Evotec, which also owns the CDMO Aptuit, has acquired the ‘Biopark by Sanofi’ (BBS) operation in Toulouse, France, and will rename it ‘Campus Curie’. The 19 employees are all transferring. Financial terms were not disclosed.

The company said that this acquisition will allow it “to significantly expand its existing capacities at the site over the near to mid-term while retaining maximum flexibility to build up long-term capacity as needed”.